IO Biotech Provides Update Following Pre-BLA Meeting with FDA
View all comments(0)
Sept 29 (Reuters) - IO Biotech Inc IOBT.O:
IO BIOTECH PROVIDES UPDATE FOLLOWING PRE-BLA MEETING WITH FDA
IO BIOTECH INC - FDA RECOMMENDS IO BIOTECH NOT SUBMIT BLA FOR IOB-013
IO BIOTECH INC - PLANS NEW STUDY FOR CYLEMBIO IN MELANOMA
IO BIOTECH INC - TO REDUCE WORKFORCE BY ABOUT 50%
IO BIOTECH INC - EXPECTS $1.0 MILLION-$1.5 MILLION CHARGE IN Q3 2025
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

Tradingkey







Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.